Literature DB >> 15962080

Edema and malignancy in meningiomas.

Tobias Alécio Mattei1, Josias Alécio Mattei, Ricardo Ramina, Paulo Henrique Aguiar, José Pindaro Plese, Raul Marino.   

Abstract

PURPOSE: In recent years there have been many attempts to define a subset of aggressive malignant meningiomas based on histopathology and imaging technologies. The purpose of this study was to evaluate the level of peritumoral edema and its volume using the imaging technologies, computer tomography and magnetic resonance imaging, and correlate these results with the histological WHO classification. Reported causes of tumoral edema and its relationships to the histological characteristics were also reviewed.
METHODS: The cases of 55 patients with meningiomas who underwent surgery at the Hospital das Clinicas (Fac Med Univ Sao Paulo) between September 1993 and September 1997 were reviewed. The level of edema according to the classification of Ide et al. (1995) was compared to the histological WHO classification.
RESULTS: Classification of the degree of edema was: level 0 edema--28 cases ; level I edema--19 cases; level II edema--8 cases. Histological classification was: benign meningioma--43 cases; atypical meningiomas--11 cases; malignant meningioma--1 case. There was a significant (P=.0089) correlation between the degree of tumoral edema and the histological characteristics.
CONCLUSIONS: These results suggest that the degree of edema as revealed by computer tomography and magnetic resonance imaging can be an important clinical predictive factor for the histological grade of the meningioma.

Entities:  

Mesh:

Year:  2005        PMID: 15962080     DOI: 10.1590/S1807-59322005000300004

Source DB:  PubMed          Journal:  Clinics (Sao Paulo)        ISSN: 1807-5932            Impact factor:   2.365


  8 in total

1.  Two-Staged Approach for Giant Hypervascular Meningioma Resection.

Authors:  Ahmed Ansari; Sadaf Riyaz
Journal:  Asian J Neurosurg       Date:  2020-04-07

2.  Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas.

Authors:  Alexandros Theodoros Panagopoulos; Carmen Lucia Penteado Lancellotti; José Carlos Esteves Veiga; Paulo Henrique Pires de Aguiar; Alison Colquhoun
Journal:  J Neurooncol       Date:  2008-04-17       Impact factor: 4.130

3.  Expression of aquaporin 5 and the AQP5 polymorphism A(-1364)C in association with peritumoral brain edema in meningioma patients.

Authors:  Nicole Lambertz; Nicolai El Hindy; Cordula Adler; Katharina Rump; Michael Adamzik; Kathy Keyvani; Agnes Bankfalvi; Winfried Siffert; I Erol Sandalcioglu; Hagen S Bachmann
Journal:  J Neurooncol       Date:  2013-02-08       Impact factor: 4.130

4.  Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas.

Authors:  Takahiro Sakuma; Takao Nakagawa; Kazunori Ido; Hiroaki Takeuchi; Kazufumi Sato; Toshihiko Kubota
Journal:  J Neurooncol       Date:  2008-06       Impact factor: 4.130

5.  Acute cerebral infarction masked by a brain tumor.

Authors:  Kwo-Whei Lee; Chung-Ping Lo
Journal:  Case Rep Neurol       Date:  2011-08-12

6.  Surgical Outcome of Treating Grades II and III Meningiomas: A Report of 32 Cases.

Authors:  Konstantinos Violaris; Vasileios Katsarides; Maria Karakyriou; Pavlos Sakellariou
Journal:  Neurosci J       Date:  2012-11-05

7.  Preoperative Evaluation of Tumor Adhesion to Adjacent Brain Tissue in Patients with Meningioma with BSMI Method and Its Comparison with the Width of Edema Around Tumor

Authors:  Sonia Rezaei; Fariborz Faeghi; Mohammad Samadian; Babak Shekarchi
Journal:  Asian Pac J Cancer Prev       Date:  2018-07-27

8.  Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema.

Authors:  Joanna Reszec; Adam Hermanowicz; Robert Rutkowski; Piotr Bernaczyk; Zenon Mariak; Lech Chyczewski
Journal:  J Neurooncol       Date:  2013-07-23       Impact factor: 4.130

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.